Skip to main content

Are you Dr. Coughlin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 43 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    34th & Civic Center Blvd
    Children's Hospital Of Philadelphia
    Philadelphia, PA 19104
    Phone+1 215-590-1000
    Fax+1 215-561-0959
  • Is this information wrong?

Summary

  • Dr. Christina Coughlin, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2001 - 2004
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1999 - 2001
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1999

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2001 - 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • CytoImmune Therapeutics Appoints Remus Vezan, M.D., Ph.D., as Chief Medical Officer
    CytoImmune Therapeutics Appoints Remus Vezan, M.D., Ph.D., as Chief Medical OfficerSeptember 7th, 2022
  • CytoImmune to Present New Preclinical Data Highlighting Potential of Novel TRACK-NK Cell Therapies as Treatments for Both Solid Tumors and Hematologic Malignancies
    CytoImmune to Present New Preclinical Data Highlighting Potential of Novel TRACK-NK Cell Therapies as Treatments for Both Solid Tumors and Hematologic MalignanciesMarch 8th, 2022
  • City of Hope and CytoImmune Announce Study Demonstrating Novel Off-the-Shelf Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell-Based Therapy Against Pancreatic Cancer
    City of Hope and CytoImmune Announce Study Demonstrating Novel Off-the-Shelf Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell-Based Therapy Against Pancreatic CancerJanuary 18th, 2022
  • Join now to see all